| n-methyl-2-phenoxy-ethylamin |
37421-04-8 |
C9H13NO |
| 5-(Bromomethyl)-1h-indazole hydrobromide |
192369-93-0 |
C8H7N2Br.HBr |
| (S)-5,8a-Dimethyl-3,4,8,8a-tetrahydro-2H,7H-naphthalene-1,6-dione |
41722-49-0 |
C12H16O2 |
| ACETOBROMO-ALPHA-D-GLUCURONIC ACID METHYL ESTER |
21085-72-3 |
C13H17O9Br |
| 2,3,4-TRI-O-ACETYL-BETA-D-GLUCURONIC ACID METHYL ESTER |
73464-50-3 |
C13H18O10 |
| METHYL 1,2,3,4-TETRA-O-ACETYL-BETA-D-GLUCURONATE |
533934-74-6 |
C15H20O11 |
| (R)-3-Amino-1,2,3,4-tetrahydrocarbazole |
116650-33-0 |
C12H14N2 |
| LY2603618 |
911222-45-2 |
C18H22N5O3Br |
| N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide |
439575-02-7 |
C32H41N5O4S2 |
| McMMAF |
863971-19-1 |
C49H76N6O11 |
| Val-Cit-PAB-MMAE |
644981-35-1 |
|
| Fmoc-Val-Cit-PAB-MMAE |
1350456-56-2 |
|
| VcMMAE |
646502-53-6 |
|
| 6-Maleimidocaproic acid |
55750-53-3 |
C10H13NO4 |
| Maleimidocaproyl-monomethylauristatin E |
863971-24-8 |
C49H78N6O10 |
| Hh-Ag1.5 |
612542-14-0 |
|
| SC-560 |
188817-13-2 |
C17H12N2OF3Cl |
| LGB-321 HCl |
1469925-36-7 |
|
| CX-3543 |
865311-47-3 |
C35H33N6O3F |
| BQ-788 |
156161-89-6 |
C34H50N5O7-.Na+ |
| MGL-3196 |
920509-32-6 |
C17H12Cl2N6O4 |
| BMS-345541 |
445430-58-0 |
C14H17N5 |
| 3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
1001917-37-8 |
C25H21N5O3S |
| Hesperadin |
422513-13-1 |
C29H32N4O3S.HCl |
| Suvorexant intermediate |
1030377-31-1 |
|
| 1H-1,4-Diazepine-1-carboxylic acid, hexahydro-5-Methyl-, phenylMethyl ester, (5R)- |
1001401-60-0 |
C14H20N2O2 |
| Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride |
1021298-67-8 |
C8H14N2O.HCl |
| 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile |
763114-25-6 |
C16H8NO2F |
| 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid |
61260-15-9 |
C10H11O5P |
| (3R)-1-Methylpyrrolidin-3-amine |
457097-75-5 |
C5H12N2 |
| ETHYL 5-METHYL-1H-IMIDAZOLE-4-CARBOXYLATE |
51605-32-4 |
C7H10N2O2 |
| 3-Amino-4-chlorophenol |
16026-77-0 |
C6H6NOCl |
| 5,6-DIHYDROXYINDOLE |
3131-52-0 |
C8H7NO2 |
| Methyltrienolone |
965-93-5 |
C19H24O2 |
| Gefitinib |
184475-35-2 |
C22H24N4O3FCl |
| 2,4-Diamino-6-hydroxypyrimidine |
56-06-4 |
C4H6N4O |
| Poly (acrylic acid-co-hypophosphite) sodium salt |
1698-60-8 |
C10H8N3OCl |
| 2'-(Oxiranylmethoxy)-3-phenylpropiophenon |
22525-95-7 |
C18H18O3 |
| 4-Chloro-2-fluoroaniline |
57946-56-2 |
C6H5NFCl |
| Cefoperazone |
62893-19-0 |
C25H27N9O8S2 |
| Olopatadine hydrochloride |
140462-76-6 |
C21H23NO3.HCl |
| FLUTICASONE PROPIONATE |
80474-14-2 |
C25H31F3O5S |
| Mometasone furoate |
83919-23-7 |
C27H30Cl2O6 |
| GSK1349572sodiuMsalt;DOLUTEGRAVIRSODIUM;GSK1349572A;Dolutegravir sodiuM salt;Dolutegravir SodiuM ( API) |
1051375-19-9 |
C20H18N3O5F2-.Na+ |
| Dolutegravi;GSK1349572;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;S/GSK1349572(GSK1349572);Dolutegravir;GSK1349572(dolutegravir);S/GSK1349572 |
1051375-16-6 |
C20H19N3O5F2 |
| Chenodeoxycholic acid;URSODEOXYCHOLOCACID;3,7-dihydroxy-,(3-alpha,5-beta,7-alpha)-cholan-24-oicaci;3,7-dihydroxy-,(3alpha,5beta,7alpha)-cholan-24-oicaci;3,7-Dihydroxy-5-Cholanicacid;3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oicaci;3-alpha,7-alpha-dihydro |
474-25-9 |
2[C28H42N6O12S] |
| 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one |
1438383-89-1 |
C19H14O3Br2 |
| (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline;(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid;(2S,4S)-1-((R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidine-2-carboxylicacid;(5S)-N-(Methoxycarbonyl |
1335316-40-9 |
|
| (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylicacid1-(1,1-dimethylethyl)ester;GS-5816interM |
1378388-16-9 |
C12H21NO5 |
| Velpatasvir intermediate;VP N-3; (2R,4R)-1-tert-butyl2-(2-(9-((2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carbonyloxy)-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 4-(methoxymethyl)pyrrolidine-1,2 |
1378391-43-5 |
|
| Velpatasvir intermediate;tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate |
1378391-44-6 |
|
| tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate |
1378391-45-7 |
|
| Ledipasvir (acetone) |
1441674-54-9 |
|
| (S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid |
129634-44-1 |
C12H19NO4 |
| Triflusal |
322-79-2 |
C10H7O4F3 |
| Propionyl-L-carnitine hydrochloride |
119793-66-7 |
C10H19NO4.HCl |
| Ibandromate Monosodium |
138926-19-9 |
C9H22O7Np2Na |
| Ibandronate sodiuM |
138844-81-2 |
C9H22NO7P2-.Na+ |
| 4,5-DiMethyl-1,3-dioxol-2-one |
37830-90-3 |
C5H6O3 |
| (4-Nitrophenyl)Methanesulfonyl chloride |
4025-75-6 |
C7H6NO4Scl |
| Tenofovirdisoproxil fuMarate |
202138-50-9 |
C19H30N5O10P.C4H4O4 |
| Idarubicinone |
60660-75-5 |
C16H24N2O4 |
| (-)-Narwedine |
510-77-0 |
C17H19NO3.HBr |
| Wogonin |
632-85-9 |
C16H12O5 |
| Metroprolol succinate |
98418-47-4 |
2(C15H25NO3).C4H6O4 |
| ApreMilast interMediate |
253168-94-4 |
C12H19NO4S |
| (+/-)-Narwedine |
1668-86-6 |
C17H19NO3 |
| GalanthaMine base |
357-70-0 |
C17H21NO3 |
| galanthaMine hydrobroMide |
1953-04-4 |
C17H21NO3.HBr;C17H22BrNO3 |
| EsoMeprazole MagnesiuM trihydrate |
217087-09-7 |
2(C17H18N3O3S).Mg.3(H2O) |
| diethyl(3-pyridyl)borane |
89878-14-8 |
C9H14BN |
| CIS-5-NORBORNENE-EXO-2,3-DICARBOXYLIC ANHYDRIDE |
2746-19-2 |
C9H8O3 |
| Azilsartan kaMedoxoMil |
863031-24-7 |
C30H23N4O8-.K |
| AgMatine sulfate |
2482-00-0 |
C5H14N4.H2O4S |
| abiraterone |
154229-19-3 |
C24H31NO |
| 6-Chlorouracil |
4270-27-3 |
C4H3N2O2Cl |
| 5-Methoxy-2-MercaptobenziMidazole |
37052-78-1 |
C8H8N2Os |
| 3-Piperazinobenzisothiazole hydrochloride |
144010-02-6 |
C11H13N3S.HCl |
| 17-Iodoandrosta-5,16-dien-3beta-ol |
32138-69-5 |
C19H27OI |
| 17-Iodoandrosta-5,16-dien-3beta-acetate ester |
114611-53-9 |
C21H29O2I |
| 1,3-DiMethylpentylaMine |
105-41-9 |
C7H17N |
| (S)-3-AMinopiperidine dihydrochloride |
334618-07-4 |
C5H12N2.2[HCl] |
| N-BENZYLOXYCARBONYL-3-FLUORO-4-MORPHOLINOANILINE |
168828-81-7 |
C18H19N2O3F |
| 4-(2-FLUORO-4-NITRO-PHENYL)-MORPHOLINE |
2689-39-6 |
C10H11N2O3F |
| 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carboxylic acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)Methyl ester |
863031-21-4 |
C30H24N4O8 |
| 3-(N-MethylpentylaMino)propionic acid hydrochloride |
625120-81-2 |
C9H19NO2.HCl |
| OlMesartan |
144689-24-7 |
C24H26N6O3 |
| 2-[(6-CHLORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)METHYL]BENZONITRILE |
865758-95-8 |
C12H8N3O2Cl |
| Benzonitrile,2-[(6-chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2H)-pyriMidinyl)Methyl]- |
865758-96-9 |
C13H10N3O2Cl |
| Ufiprazole |
73590-85-9 |
C17H19N3O2S |
| Ibandronic acid |
114084-78-5 |
C9H23NO7P2 |
| EsoMeprazole MagnesiuM |
161973-10-0 |
2(C17H18N3O3S)2.Mg |
| EsoMeprazole |
119141-88-7 |
C17H19N3O3S |
| Alogliptin |
850649-61-5 |
C18H21N5O2 |
| AlMotriptan |
154323-57-6 |
C17H25N3O2S |
| 5-(4'-BroMoMethyl-1,1'-biphenyl-2-yl)-1-triphenylMethyl-1H-tetrazole |
124750-51-2 |
C33H25N4Br |
| 2-(1,2-Benzisoxazol-3-yl)acetic acid |
4865-84-3 |
C9H7NO3 |
| 1-[[(4-Nitrophenyl)Methyl]sulfonyl]-pyrrolidine |
340041-91-0 |
C11H14N2O4S |
| 1-[[(4-AMinophenyl)Methyl]sulfonyl]-pyrrolidine |
334981-10-1 |
C11H16N2O2S |
| 1,2-Benzisoxazole-3-Methanesulfonic acid sodiuM salt |
73101-64-1 |
C8H6NO4S-.Na+ |
